These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 39011955)
1. Predictors of Shock-Reduction Programming and Its Impact on Implantable Cardioverter-Defibrillator Therapies and Mortality: The CERTITUDE Registry. Beyer SE; Harrell C; Mullane S; Kutyifa V; Madhavan M; Piccini JP; Upadhyay GA; Ip JE; Thomas G; Liu CF; Markowitz SM; Hayes D; Lerman BB; Cheung JW J Am Heart Assoc; 2024 Aug; 13(15):e034500. PubMed ID: 39011955 [TBL] [Abstract][Full Text] [Related]
2. Impact of programming strategies aimed at reducing nonessential implantable cardioverter defibrillator therapies on mortality: a systematic review and meta-analysis. Tan VH; Wilton SB; Kuriachan V; Sumner GL; Exner DV Circ Arrhythm Electrophysiol; 2014 Feb; 7(1):164-70. PubMed ID: 24446023 [TBL] [Abstract][Full Text] [Related]
3. Device Therapies Among Patients Receiving Primary Prevention Implantable Cardioverter-Defibrillators in the Cardiovascular Research Network. Greenlee RT; Go AS; Peterson PN; Cassidy-Bushrow AE; Gaber C; Garcia-Montilla R; Glenn KA; Gupta N; Gurwitz JH; Hammill SC; Hayes JJ; Kadish A; Magid DJ; McManus DD; Multerer D; Powers JD; Reifler LM; Reynolds K; Schuger C; Sharma PP; Smith DH; Suits M; Sung SH; Varosy PD; Vidaillet HJ; Masoudi FA J Am Heart Assoc; 2018 Mar; 7(7):. PubMed ID: 29581222 [TBL] [Abstract][Full Text] [Related]
4. Clinical outcome in patients with implantable cardioverter-defibrillator and cancer: a nationwide study. Christensen AM; Bjerre J; Schou M; Jons C; Vinther M; Gislason GH; Johansen JB; Nielsen JC; Petersen HH; Riahi S; Ruwald AC Europace; 2019 Mar; 21(3):465-474. PubMed ID: 30535192 [TBL] [Abstract][Full Text] [Related]
5. Very high rate programming in primary prevention patients with reduced ejection fraction implanted with a defibrillator: Results from a large multicenter controlled study. Clementy N; Challal F; Marijon E; Boveda S; Defaye P; Leclercq C; Deharo JC; Sadoul N; Klug D; Piot O; Gras D; Bordachar P; Algalarrondo V; Fauchier L; Babuty D; Heart Rhythm; 2017 Feb; 14(2):211-217. PubMed ID: 27989789 [TBL] [Abstract][Full Text] [Related]
6. Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT). Ruwald AC; Schuger C; Moss AJ; Kutyifa V; Olshansky B; Greenberg H; Cannom DS; Estes NA; Ruwald MH; Huang DT; Klein H; McNitt S; Beck CA; Goldstein R; Brown MW; Kautzner J; Shoda M; Wilber D; Zareba W; Daubert JP Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):785-92. PubMed ID: 25136077 [TBL] [Abstract][Full Text] [Related]
7. Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention. Khazanie P; Hellkamp AS; Fonarow GC; Bhatt DL; Masoudi FA; Anstrom KJ; Heidenreich PA; Yancy CW; Curtis LH; Hernandez AF; Peterson ED; Al-Khatib SM J Am Heart Assoc; 2015 Aug; 4(8):e002061. PubMed ID: 26251283 [TBL] [Abstract][Full Text] [Related]
8. Mortality Implications of Appropriate Implantable Cardioverter Defibrillator Therapy in Secondary Prevention Patients: Contrasting Mortality in Primary Prevention Patients From a Prospective Population-Based Registry. Almehmadi F; Porta-Sánchez A; Ha ACT; Fischer HD; Wang X; Austin PC; Lee DS; Nanthakumar K J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862957 [TBL] [Abstract][Full Text] [Related]
9. Effectiveness of subcutaneous implantable cardioverter-defibrillators and determinants of inappropriate shock delivery. Mesquita J; Cavaco D; Ferreira A; Lopes N; Santos PG; Carvalho MS; Haas A; Costa F; Carmo P; Morgado F; Adragão P; Mendes M Int J Cardiol; 2017 Apr; 232():176-180. PubMed ID: 28082086 [TBL] [Abstract][Full Text] [Related]
10. Incidence of and predictors for appropriate implantable cardioverter-defibrillator therapy in patients with a secondary preventive implantable cardioverter-defibrillator indication. Schaer B; Kühne M; Reichlin T; Osswald S; Sticherling C Europace; 2016 Feb; 18(2):227-31. PubMed ID: 26063686 [TBL] [Abstract][Full Text] [Related]
13. Predictors of Subcutaneous Implantable Cardioverter-Defibrillator Shocks and Prognostic Impact in Patients With Structural Heart Disease. Ninni S; Echivard M; Marquié C; Ortmans S; Labreuche J; Drumez E; Lemaire J; Cuvillier A; Arnaud M; Potelle C; Gouraud JB; Andorin A; Blangy H; Sadoul N; Probst V; Klug D Can J Cardiol; 2021 Mar; 37(3):400-406. PubMed ID: 32474109 [TBL] [Abstract][Full Text] [Related]
14. Implant and clinical characteristics for pediatric and congenital heart patients in the national cardiovascular data registry implantable cardioverter defibrillator registry. Jordan CP; Freedenberg V; Wang Y; Curtis JP; Gleva MJ; Berul CI Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1092-100. PubMed ID: 25287482 [TBL] [Abstract][Full Text] [Related]
15. Implantable cardioverter defibrillators in patients with electrical heart disease and hypertrophic cardiomyopathy: data from the German device registry. Frommeyer G; Reinke F; Andresen D; Kleemann T; Spitzer SG; Jehle J; Brachmann J; Stellbrink C; Hochadel M; Senges J; Eckardt L Clin Res Cardiol; 2020 Apr; 109(4):508-512. PubMed ID: 31367999 [TBL] [Abstract][Full Text] [Related]
16. Intensive recreational athletes in the prospective multinational ICD Sports Safety Registry: Results from the European cohort. Heidbuchel H; Willems R; Jordaens L; Olshansky B; Carre F; Lozano IF; Wilhelm M; Müssigbrodt A; Huybrechts W; Morgan J; Anfinsen OG; Prior D; Mont L; Mairesse GH; Boveda S; Duru F; Kautzner J; Viskin S; Geelen P; Cygankiewicz I; Hoffmann E; Vandenberghe K; Cannom D; Lampert R Eur J Prev Cardiol; 2019 May; 26(7):764-775. PubMed ID: 30813818 [TBL] [Abstract][Full Text] [Related]
17. Trends in implantable cardioverter-defibrillator programming practices and its impact on therapies: Insights from a North American Remote Monitoring Registry 2007-2018. Bennett MT; Brown ML; Koehler J; Lexcen DR; Cheng A; Cheung JW Heart Rhythm; 2022 Feb; 19(2):219-225. PubMed ID: 34656774 [TBL] [Abstract][Full Text] [Related]
18. Dutch Outcome in Implantable Cardioverter-Defibrillator Therapy: Implantable Cardioverter-Defibrillator-Related Complications in a Contemporary Primary Prevention Cohort. van Barreveld M; Verstraelen TE; van Dessel PFHM; Boersma LVA; Delnoy PPHM; Tuinenburg AE; Theuns DAMJ; van der Voort PH; Kimman GJ; Buskens E; Zwinderman AH; Wilde AAM; Dijkgraaf MGW; J Am Heart Assoc; 2021 Apr; 10(7):e018063. PubMed ID: 33787324 [TBL] [Abstract][Full Text] [Related]
19. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators. Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811 [TBL] [Abstract][Full Text] [Related]
20. Comparative Effectiveness of Primary Prevention Implantable Cardioverter-Defibrillators in Older Heart Failure Patients With Diabetes Mellitus. Sharma A; Wu J; Xu H; Hernandez A; Felker GM; Al-Khatib S; Green J; Matsouaka R; Fonarow GC; Singh JP; Heidenreich PA; Ezekowitz JA; DeVore A J Am Heart Assoc; 2020 Jun; 9(12):e012405. PubMed ID: 32476539 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]